Pregled bibliografske jedinice broj: 1103947
A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries
A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries // European journal of cancer (1990), 135 (2020), 130-146 doi:10.1016/j.ejca.2020.05.015 (međunarodna recenzija, članak, ostalo)
CROSBI ID: 1103947 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
A review of the international early
recommendations for departments organization and
cancer management priorities during the global
COVID-19 pandemic: applicability in low- and
middle-income countries
Autori
Belkacemi, Yazid ; Grellier, Noemie ; Ghith, Sahar ; Debbi, Kamel ; Coraggio, Gabriele ; Bounedjar, Adda ; Samlali, Redouane ; Tsoutsou, Pauletta G. ; Ozsahin, Mahmut ; Chauvet, Marie-Pierre ; Turkan, Sedat ; Boussen, Hamouda ; Kuten, Abraham ; Tesanovic, Dusanka ; Errihani, Hassan ; Benna, Farouk ; Bouzid, Kamel ; Idbaih, Ahmed ; Mokhtari, Karima ; Popovic, Lazar ; Spano, Jean-Philippe ; Lotz, Jean-Pierre ; Cherif, Aziz ; To, Hahn ; Kovcin, Vladimir ; Arsovski, Oliver ; Beslija, Semir ; Dzodic, Radan ; Markovic, Ivan ; Vasovic, Suzana ; Stamatovic, Liljana ; Radosavljevic, Davorin ; Radulovic, Sinisa ; Vrbanec, Damir ; Sahraoui, Souha ; Vasev, Nino ; Stojkovski, Igor ; Risteski, Milan ; Freixa, Salvador Villà ; Krengli, Marco ; Radosevic, Nina ; Mustacchi, Giorgio ; Filipovic, Mladen ; Kerrou, Khaldoun ; Taghian, Alphonse G. ; Todorovic, Vladimir ; Geara, Fady ; Gligorov, Joseph
Izvornik
European journal of cancer (1990) (0959-8049) 135
(2020);
130-146
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
cancer ; COVID-19 ; guidelines ; recommendations ; LMICs ; health care ; TRONE ; AROME
Sažetak
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new virus that has never been identified in humans before. COVID-19 caused at the time of writing of this article, 2.5 million cases of infections in 193 countries with 165, 000 deaths, including two- third in Europe. In this context, Oncology Departments of the affected countries had to adapt quickly their health system care and establish new organizations and priorities. Thus, numerous recommendations and therapeutic options have been reported to optimize therapy delivery to patients with chronic disease and cancer. Obviously, while these cancer care recommendations are immediately applicable in Europe, they may not be applicable in certain emerging and low- and middle-income countries (LMICs). In this review, we aimed to summarize these international guidelines in accordance with cancer types, making a synthesis for daily practice to protect patients, staff and tailor anti-cancer therapy delivery taking into account patients/tumour criteria and tools availability. Thus, we will discuss their applicability in the LMICs with different organizations, limited means and different constraints.
Izvorni jezik
Engleski
Znanstvena područja
Interdisciplinarne prirodne znanosti, Javno zdravstvo i zdravstvena zaštita, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Sveučilište Jurja Dobrile u Puli
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE